Patent Classification

Controlled/Sustained/Delayed Release  Drug Delivery System, General

1. Polymer-based sustained release device
    
2. Modified release dosage form
    
3. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
    
4. Once a day antihistamine and decongestant formulation
    
5. Methods for the treatment of bipolar disorder using carbamazepine
    
6. Paroxetine controlled release compositions
    
7. Controlled-release pharmaceutical formulations
    
8. Sustained-release microencapsulated delivery system
    
9. Coating for a sustained release pharmaceutical composition
    
10. Blend, cross-linkable poly(propylene fumarate) for immobilization and controlled drug delivery
     
11. Once-a-day controlled release sulfonylurea formulation
     
12. Membrane or matrix for controlling the permeation rate of drugs
     
13. Multiphase active ingredient-containing formulations
     
14. Controlled release composition
     
15. Collagen preparation for the controlled release of active substances
     
16. Long time drug-sustained release preparation
     
17. Slow release protein polymers
     
18. Controlled release liquid delivery compositions with low initial drug burst
     
19. Amoxicillin-clarithromycin antibiotic composition
     
20. Composition for sustained release of human growth hormone
     
21. Controlled release of metal cation-stabilized interferon
    
    
22. Self-destructing, controlled release peroral drug delivery system
    
    
23. Pharmaceutical dosage form for pulsatile delivery of methylphenidate
     
    
24. Sustained release carbamazepine pharmaceutical composition free of food effect and a method for alleviating food effect in drug release
     
    
25. Process for the preparation of a controlled release system
     
    
26. Process for the preparation of polymer-based sustained release compositions
     
    
27. Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
     
    
28. Drug delivery system using galactoxyloglucan
     
    
29. High load formulations and methods for providing prolonged local anesthesia
     
    
30. Sustained-release preparation utilizing thermal change and process for the production thereof
     
    
31. Maximizing effectiveness of substances used to improve health and well being
     
    
32. Controlled release delivery of peptide or protein
     
    
33. Once daily analgesic tablet
     
    
34. Sustained release theophylline formulations, excipient systems and methods of production
     
    
35. Controlled release drug delivery
     
    
36. Sustained release compositions and a method of preparing pharmaceutical compositions
     
    
37. Controlled release chromium picolinate
     
    
38. System for delaying drug delivery up to seven hours
     
    
39. Delayed release coated tablet of bupropion hydrochloride
     
    
40. Sustained release compositions and a method of preparing pharmaceutical compositions
     
    
41. Controlled dissolution crosslinked protein crystals
     
    
42. Sustained release heterodisperse hydrogel systems for insoluble drugs
     
    
43. Extended-release solid oral dosage forms of drugs having low solubility in water
     
    
44. Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
     
    
45. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
     
    
46. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
     
    
47. Extended release acetaminophen particles
     
    
48. Cisapride sustained release
     
    
49. Sustained release particles
     
    
50. Non-polymeric sustained release delivery system
     
    
51. Prolonged release active agent dosage form adapted for gastric retention
     
    
52. Oral formulations for controlled release of alcohol deterrents
     
    
53. Prolonged release of GM-CSF
     
    
54. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
     
    
55. Sustained-release preparation capable of releasing a physiologically active substance
     
    
56. Cisapride mini-tablet formulations
     
    
57. Once daily analgesic tablet
     
    
58. Sustained-release metal valproate tablets
     
    
59. Delayed pulse release hydrogel matrix tablet
     
    
60. Controlled release oral tablet having a unitary core
     
    
61. Oral dosage form for the controlled release of a biguanide and sulfonylurea
     
    
62. Delayed release tablet of bupropion hydrochloride
     
    
63. Extended-release chemical formulation in tablet form for urine pretreatment
     
    
64. Sustained release matrix for high-dose insoluble drugs
     
    
65. Sustained release formulation containing three different types of polymers and tablet formed therefrom
     
    
66. Polymeric matrices and their uses in pharmaceutical compositions
     
    
67. Layered tablet for the controlled release of active substances
     
    
68. Pharmaceutical compositions for controlled release of soluble receptors
     
    
69. Controlled release tablet compositions
     
    
70. Pharmaceutical composition containing a fusible carrier and method for producing the same
     
    
71. Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
     
    
72. Controlled-release dosage forms of Azithromycin
     
    
73. Sustained release delivery system
     
    
74. Pharmaceutical drug dosage forms providing different release rates
     
    
75. Elastomer, its preparation and use
     
    
76. Once-a-day controlled release sulfonylurea formulation
     
    
77. Composition for sustained release of human growth hormone
     
    
78. Controlled-release, drug-delivery composition
     
    
79. Formulations and methods for providing prolonged local anesthesia
     
    
80. Sustained-release liposomal anesthetic compositions
     
    
81. Sustained release excipient
     
    
82. Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
     
    
83. Dosage form and method for administering drug
     
    
84. Controlled release tablet of bupropion hydrochloride
     
    
85. Calcium sulfate controlled release matrix
     
    
86. Sustained release capsule and method for preparing the same
     
    
87. Extended release clonidine formulation (capsule)
     
    
88. Sustained-release granular preparations and production process thereof
     
    
89. Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption
     
    
90. Immediate release tablet cores of insoluble drugs having sustained-release coating
     
    
91. Immobilized and activity-stabilized complexes of LHRH antagonists and processes for their preparation
     
    
92. Banded prolonged release active agent dosage form
     
    
93. Sustained delivery device comprising a Leishmania protozoa and methods of making and using the same
     
    
94. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
     
    
95. Extended release formulations of erythromycin derivatives
     
    
96. Sustained-release protein formulations
     
    
97. Sustained release delivery system
     
    
98. Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
     
    
99. Polymeric lamellar substrate particles for drug delivery
     
    
100. Timed release tablet comprising naproxen and pseudoephedrine
      
     
101. Sustained-release matrices for dental application
      
     
102. Microgels
      
     
103. Two-phase matrix for sustained release drug delivery device
      
     
104. Drug delivery system for two or more active substances
      
     
105. Pharmaceutical composition for the programmed release of dexfenfluramine
      
     
106. Sustained release drug formulations
      
     
107. Zero-order sustained release matrix tablet formulations of carbamazepine
      
     
108. Polymer gel for medical use
      
     
109. Composition for the delivery of orally administered drugs and other substances
      
     
110. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
      
     
111. Use of biologically active glass as a drug delivery system
      
     
112. Sustained release pharmaceutical preparation
      
     
113. Orally administrable opioid formulations having extended duration of effect
      
     
114. Polymers with controlled physical state and bioerodibility
      
     
115. High viscosity liquid controlled delivery system as a device
      
     
116. Dosage units
      
     
117. Recipient-dosage delivery system
      
     
118. Substained release compositions and a method of preparing pharmaceutical compositions
      
     
119. Process for producing porous, controlled-release capsules and encapsulated composition
      
     
120. Controlled release formulation (albuterol)
      
     
121. Opioid formulations having extended controlled released
      
     
122. Multiple unit oral pharmaceutical formulations
      
     
123. Cross-linked microparticles and their use as therapeutic vehicles
      
     
124. Controlled release preparation for administering morphine
      
     
125. Modified release matrix formulation of cefaclor and cephalexin
      
     
126. Gelified microspheres, their method of preparation and their applications
      
     
127. Controlled release tablet
      
     
128. Formulations and methods for providing prolonged local anesthesia
      
     
129. Local oral herbal slow release tablets
      
     
130. Prolonged release of GM-CSF
      
     
131. Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
      
     
132. Controlled release of substances
      
     
133. Controlled release preparations for cytotoxic or cytostatic drugs
      
     
134. Budesonide pellets with a controlled released pattern and process for producing the same
      
     
135. Peroral composition for controlled release in the lower gastrointestinal tract
      
     
136. Controlled release insufflation carrier for medicaments